NCT07090109Not yet recruiting
PITCH - Impacting Hereditary Cancer Testing
Partnering to Impact Testing in the Commonwealth for Hereditary Cancers (PITCH)
Source: ClinicalTrials.gov · Last updated 10 Sept 2026
Brief summary (registry, in English)
The goal of this clinical trial is to assess patients' knowledge and attitudes about genetic testing before and after viewing an educational video. The main questions it aims to answer are: * Did the video change participants' knowledge and attitudes about genetic testing? * Did participants make an informed choice about pursuing genetic testing? Participants will: * Complete a baseline survey * View educational video * Complete follow-up survey
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 200 (estimated)
- First submitted
- 22 Jul 2025
- Start date
- 1 Apr 2027
- Primary completion date
- 31 Jul 2027
- Lead sponsor
- Rachel Miller
- Diseases
- Ovarian cancer
- NCT number
- NCT07090109
What you commit to
- Study type: Interventional
- Planned participants: 200
- From 1 Apr 2027 to the primary completion date, 31 Jul 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- previously undergone multi-gene panel testing for hereditary cancers
Who the study is looking for
- diagnosed with a cancer that can be associated with hereditary forms of cancer
Age in the registry: 18 years to - · Sex: Female · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Kentucky Coordinator of this site? Confirm its status | Lexington | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.